Categories
Change Password!
Reset Password!
Smartphone-based acceptance and commitment intervention provides a favourable approach for managing fibromyalgia, particularly considering the accessibility challenges related to traditional cognitive behavioural treatments.
Digital acceptance and commitment therapy (ACT) is both safe and highly effective in managing fibromyalgia, surpassing traditional digital symptom tracking in adult patients, as per a phase 3 study published in Lancet (London, England).
This trial by R Michael Gendreau et al., known as PROSPER-FM, aimed to assess the impact of a 12-week, self-paced, smartphone-based digital ACT program for fibromyalgia treatment. Conducted across 25 community sites in the US, the study enrolled 275 participants, aged 22-75 years. They were assigned to either the digital ACT group or an active control group that used everyday symptom tracing along with educational means about fibromyalgia.
Improvements in patients' overall condition, using a patient global impression of change (PGIC) score after 12 weeks was the primary goal of this trial. As revealed, 71% of participants in the digital ACT group reported significant improvements, compared to just 22% in the control group. This difference was statistically significant, with less than 0.0001 as the p-value. No device-related safety issues were reported, underlining the digital ACT's safety alongside its effectiveness.
Lancet (London, England)
Self-guided digital behavioural therapy versus active control for fibromyalgia (PROSPER-FM): a phase 3, multicentre, randomised controlled trial
R Michael Gendreau et al.
Comments (0)